Literature DB >> 2455591

Prognostic factors in advanced nonseminomatous testicular cancer. A multivariate logistic regression analysis.

J P Droz1, A Kramar, M Ghosn, G Piot, A Rey, C Theodore, P Wibault, B H Court, J L Perrin, J P Travagli.   

Abstract

In order to define prognostic factors for advanced stage of nonseminomatous germ cell tumors (NSGCT) of the testis, the authors reviewed 84 patients treated from 1978 through 1985. The survival rate was 51% at 3 years. Patients with elevated seric levels of human chorionic gonadotropin (HCG) and/or alpha-fetoprotein (AFP), or the presence of an abdominal mass had significantly worse survival. Only HCG and AFP levels retained their significance when multivariate Cox analysis was performed. The probability that a patient achieves a complete remission (CR) was assessed by a function of certain patient characteristics using a multivariate logistic regression analysis. The significant variables were a function of HCG and AFP values. Since both variables are related to the CR rate and survival the authors define the obtention of a CR as a unique outcome of interest. The probability of a CR greater than 70% adequately separates the patients into two prognostic subgroups. This model currently is being used to enrole NSGCT patients in a prospective modulated clinical trial according to these prognostic factors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2455591     DOI: 10.1002/1097-0142(19880801)62:3<564::aid-cncr2820620321>3.0.co;2-a

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Super-high-risk germ-cell tumors: a clinical entity. Report of eleven cases.

Authors:  A Moran-Ribon; J P Droz; J Kattan; B Leclercq; M Ghosn; D Couanet; M Ostronoff; S Culine; B Misset; B Escudier
Journal:  Support Care Cancer       Date:  1994-07       Impact factor: 3.603

Review 2.  Good-risk-advanced germ cell tumors: historical perspective and current standards of care.

Authors:  Darren R Feldman; Robert J Motzer
Journal:  World J Urol       Date:  2009-06-10       Impact factor: 4.226

3.  Analysis of a non-ras 21-kDa protein in patients with metastatic testicular germ-cell tumors.

Authors:  E Grundner-Culemann; C Bokemeyer; V Neubauer; C Shalitin; H J Schmoll; H Poliwoda; T Benter
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

4.  Acute respiratory distress syndrome after chemotherapy for lung metastases from non-seminomatous germ-cell tumors.

Authors:  C Kirch; F Blot; K Fizazi; B Raynard; C Theodore; G Nitenberg
Journal:  Support Care Cancer       Date:  2003-06-03       Impact factor: 3.603

5.  Acute tumor lysis syndrome in poor-risk germ cell tumors: does it exist?

Authors:  J Kattan; S Culine; T Tavakoli-Razavi; A Kramar; J P Droz
Journal:  Support Care Cancer       Date:  1994-03       Impact factor: 3.603

6.  Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminomatous testicular cancer.

Authors:  R de Wit; R Sylvester; C Tsitsa; P H de Mulder; D T Sleyfer; W W ten Bokkel Huinink; S B Kaye; A T van Oosterom; E Boven; K Vermeylen; G Stoter
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 7.  Impact of Non-Pulmonary Visceral Metastases in the Prognosis and Practice of Metastatic Testicular Germ Cell Tumors.

Authors:  Lorena Rossi; Filippo Martignano; Valentina Gallà; Antonio Maugeri; Giuseppe Schepisi
Journal:  Oncol Rev       Date:  2016-04-20

8.  Serum alpha-fetoprotein surge after the initiation of chemotherapy for non-seminomatous testicular cancer has an adverse prognostic significance.

Authors:  R de Wit; L Collette; R Sylvester; P H de Mulder; D T Sleijfer; W W ten Bokkel Huinink; S B Kaye; A T van Oosterom; E Boven; G Stoter
Journal:  Br J Cancer       Date:  1998-11       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.